Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine transdermal patches for chronic osteoarthritis pain of the hip and/or knee in different age groups
2010-020748-37Phase 4Completed
- Sponsor
- Mundipharma
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of buprenorphine in osteoarthritis (OA) (2 arms), sponsored by Mundipharma. Primary endpoint: Change in Box Scale-11 pain score from baseline to completion. Started Oct 2010; status: completed.
02
Drugs
buprenorphine
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on 2010-020748-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020748-37.